Our Projects

2022 - 2028

The role of TNF family members: identification of biomarkers and development of targeted therapies in childhood IgA nephropathy (cIgAN).

icone d'une équipe

Directed by Lison Lachize Léanne (PhD student).

icone d'une loupe

Study of the involvement of TNF members in cIgAN, in particular the interactions between APRIL, BAFF and the complement system.

2022 - 2027

Role of soluble CD89, myeloid receptor, in mesangial hypercellularity in IgA nephropathy.

icone d'une équipe

Produced by Amandine Badie (Postdoctoral Researcher) in collaboration with Dr Alexandra Dubrac and Dr Gilles Hickson.

icone d'une loupe

Study of the mechanisms by which soluble CD89 induces renal inflammation and activates the mTOR pathway, cytokines and complement via the TfR1 receptor.

2023 - 2028

Implication of the complement pathway in childhood IgA nephropathy.

icone d'une équipe

Directed by Srishti Sahu (PhD student).

icone d'une loupe

In vitro (cell models) and in vivo (patient cohort) studies to better understand the involvement of complement in cIgAN.

2024 - 2026

Role of the urinary C5b9 membrane attack complex in nephrotic syndrome in children.

icone d'une équipe

Directed by Diane Leenhardt (M.Sc.) and Dr Helene Mathieu.

icone d'une loupe

In vitro study on podocytes to evaluate complement activation and C5b9 deposition after stimulation with serum from affected patients. Analysis of the complement pathway in a cohort of patients with nephrotic syndrome.